Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,397 across all filing types
Latest filing 2019-06-03 Regulatory Filings
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
LYNPARZA NEARLY DOUBLED THE TIME PATIENTS LIVED WITHOUT DISEASE PROGRESSION FROM
Regulatory Filings
2019-06-03 English
Lynparza nearly doubled time patients lived with
Earnings Release Classification · 99% confidence The document begins with 'RNS Number : 8502A' and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This strongly indicates a regulatory announcement disseminated via the RNS system. The content itself is a press release detailing positive clinical trial results (Phase III POLO trial for Lynparza) and is dated June 3, 2019. While it contains detailed financial/scientific information, its primary function here is a broad regulatory disclosure to the market, not a comprehensive periodic report (like 10-K or IR) or a management discussion (MDA). Since it is a general regulatory announcement that doesn't fit the more specific categories like ER (Earnings Release) or DIV (Dividend Notice), the most appropriate classification is the general Regulatory Filings category. FY 2019
2019-06-03 English
Group of companies' accounts made up to 2018-12-31
Regulatory Filings
2019-05-14 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document explicitly mentions 'RNS Number', indicating it is a regulatory news service announcement from the London Stock Exchange. The content details 'Share dealings by Person Discharging Managerial Responsibility ("PDMR")' involving a Non-Executive Director (Mr Murray Scott) selling and purchasing shares. This directly corresponds to the definition of Director's Dealing (insider trades). Therefore, the appropriate code is DIRS.
2019-05-10 English
POOLED ANALYSES OF THE ROXADUSTAT GLOBAL PHASE III
Regulatory Filings
2019-05-10 English
Pooled analyses of the roxadustat global Phase III
Earnings Release Classification · 99% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement distributed via the London Stock Exchange's news service (RNS). The content details top-line results from clinical trials (Phase III programme for roxadustat) and discusses cardiovascular safety endpoints (MACE/MACE+). This type of announcement, which releases key clinical trial data and discusses future regulatory submission plans (FDA), is typically classified as an Earnings Release (ER) if it were quarterly results, or more generally, a Regulatory Filing (RNS) if it's a specific, non-standard announcement. Since it is a major announcement of clinical trial data that precedes a formal regulatory submission, and it is explicitly distributed via RNS, it fits best under the general 'Regulatory Filings' category (RNS) as it is not a full financial report (10-K, IR), a management discussion (MDA), or a formal earnings release focused on P&L/Balance Sheet figures (ER). The presence of the RNS header strongly points to this classification. FY 2019
2019-05-10 English

Browse filings by year

34 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.